HopeStage
Back to all studies
CompletedNCT00349973

Dipyridamole or olanzapine for schizophrenia symptoms

About this titleRead the official source — NCT00349973
Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
BaltimoreSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2001
Recruitment status
Completed
Enrollment listed in the registry
29
Sponsor
University of Maryland, Baltimore
Sponsor type
University
Study type
Drug
Intervention type
Drug, Other
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00349973
Official title
Show the full official title

Clinical Trial of Dipyridamole in Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Baltimore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Maryland, Baltimore, a university.

Did this study involve medication?

Yes. The study involved medication, including Dipyridamole.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies